Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1075
Bid: 0.105
Ask: 0.11
Change: 0.00125 (1.18%)
Spread: 0.005 (4.762%)
Open: 0.10625
High: 0.00
Low: 0.00
Prev. Close: 0.10625
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Umbro Launch

1 Mar 2023 12:00

RNS Number : 5423R
Versarien PLC
01 March 2023
 

 

 

 

Reach - Non-Regulatory

 

1 March 2023

 

Versarien plc

("Versarien" or the "Company")

Umbro Launch

 

Launch of Umbro's ProTraining Elite range incorporating Versarien's Graphene-Wear™

 

Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to announce the launch of Umbro's ProTraining Elite range, including garments incorporating the Company's Graphene-Wear™ technology.

 

Versarien has been working with Umbro since 2018 and these are the first products to be launched in Europe incorporating the Company's technology. Umbro's new ProTraining Elite long-sleeve running tops, baselayers and running tights have Versarien's Graphene-Wear™ ink formula printed on the inside. The Graphene-Wear™ formula features novel properties that will allow wearers to experience enhanced thermal transmittance, increased moisture management, with improved drying rate, without compromising air or water vapor permeability. In particular, these three garments will benefit significantly from applying Graphene-Wear™ as they are being worn in circumstances where maintaining core body temperature is more desirable and difficult to achieve. The garments also have Versarien's Graphene-Wear™ trademark applied.

 

In developing its proprietary Graphene-Wear™ technology, Versarien has invested in extensive wearer trials in partnership with University of Gloucestershire and in January 2023 Graphene-Wear™ secured OEKO-TEX® Eco Passport certification, all aimed at giving the Company's partners, such as Umbro, confidence in the technology.

 

Neill Ricketts, Chief Executive Officer of Versarien, said: "We are delighted that Umbro are launching their new Pro-Training Elite range onto the market, incorporating the Company's Graphene-Wear™ technology. This technology is designed to provide the garments with novel properties, in particular regarding their thermo-regulatory properties and the ability to maintain optimum body temperature, that will significantly enhance the user experience.

 

"We look forward to the Umbro ProTraining Elite garments, incorporating Graphene-Wear™, being on sale and it showcasing the viability and attractiveness of using this technology for future products."

 

 

For further information please contact:

 

Versarien Plc

Neill Ricketts - Chief Executive Officer

+44 (0) 1594 887204

Chris Leigh - Chief Financial Officer

Stephen Hodge - Chief Technology Officer

SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

Matthew Johnson, Adam Cowl

+44 (0) 20 3470 0470

Berenberg (Joint Broker)

Mark Whitmore, Ciaran Walsh

+44 (0) 20 3207 7800

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien Plc

 

The strategy of Versarien Plc (AIM:VRS) is to be a globally recognised graphene company with a wide portfolio of high-quality verified materials allied to the largest relevant IP portfolio supported by its own UK based research and development centre driving recurring revenue growth through its innovative graphene product applications.

 

For further information please see: https://www.versarien.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFFLFBXXLXBBE
Date   Source Headline
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting
9th Jun 20237:00 amRNSInterim Results
31st May 20237:00 amRNSTotal Voting Rights
17th May 20237:00 amRNSSuccessful Cementene precast concrete trials
3rd May 20239:30 amRNSPlacing and Update on Turnaround Strategy
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202311:22 amRNSResult of AGM
29th Mar 20237:00 amRNSAGM Statement
15th Mar 20237:00 amRNSPlacing to raise £318,000
14th Mar 20232:56 pmRNSFurther re Resignation of Chief Executive Officer
10th Mar 20237:00 amRNSResignation of Chief Executive Officer
6th Mar 20237:00 amRNSCostain Civil Engineering Project
1st Mar 202312:00 pmRNSUmbro Launch
28th Feb 20237:00 amRNSNotice of AGM and Posting of Annual Report
21st Feb 20237:00 amRNSResults for the 18 months ended 30 September 2022
9th Feb 20238:33 amRNSAIM Rule 17 Update
27th Jan 20237:00 amRNSGraphene-Wear OEKO-TEX Eco Passport certification
24th Jan 20231:56 pmRNSFinal Results Update
30th Dec 20227:00 amRNSTotal Voting Rights
6th Dec 20229:40 amRNSPlacing to raise £1.85 million
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSG-SCALE Update & Innovate UK Loan Variation
2nd Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.